Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J-F Riou

Showing results (41-50 of 106) with videos related to

Pageof 11
Sort By:
Biochemical Pharmacology|July 1, 1989
Topoisomerase II-mediated DNA cleavage activity induced by ellipticines on the human tumor cell line N417E Multon, J F Riou, D LeFevre, et al.
Anti-Cancer Drug Design|August 14, 1998
Synthesis, DNA binding, topoisomerase II inhibition and cytotoxicity of two guanidine-containing anthracene-9,10-dionesS Routier, J L Bernier, J P Catteau, et al.
Journal of Medicinal Chemistry|May 5, 2000
Multivariate data analysis using D-optimal designs, partial least squares, and response surface modeling: A directional approach for the analysis of farnesyltransferase inhibitorsE Giraud, C Luttmann, F Lavelle, et al.
Development (Cambridge, England)|September 1, 1992
Expression of tenascin mRNA in mesoderm during Xenopus laevis embryogenesis: the potential role of mesoderm patterning in tenascin regionalizationM Umbhauer, J F Riou, J Spring, et al.
Nucleic Acids Research|June 3, 1999
Purification and characterization of human DNA topoisomerase IIIalphaH Goulaouic, T Roulon, O Flamand, et al.
Cancer Research|January 19, 1999
Poisoning of topoisomerase I by an antitumor indolocarbazole drug: stabilization of topoisomerase I-DNA covalent complexes and specific inhibition of the protein kinase activityE Labourier, J F Riou, M Prudhomme, et al.
European Journal of Cancer (Oxford, England : 1990)|February 1, 1997
A carbamate analogue of amsacrine with activity against non-cycling cells stimulates topoisomerase II cleavage at DNA sites distinct from those of amsacrineB C Baguley, F Leteurtre, J F Riou, et al.
Cell and Tissue Research|January 1, 1986
Synthesis and distribution of laminin-related polypeptides in early amphibian embryosT Darribère, J F Riou, D L Shi, et al.
Development (Cambridge, England)|May 1, 1987
Experimental analysis of the extension of the dorsal marginal zone in Pleurodeles waltl gastrulaeD L Shi, M Delarue, T Darribère, et al.
Biochemical Pharmacology|January 26, 1993
Sequential modifications of topoisomerase I activity in a camptothecin-resistant cell line established by progressive adaptationI Madelaine, S Prost, A Naudin, et al.
Pageof 11

Showing results (41-50 of 106) with videos related to

Sort By:
Pageof 11
Biochemical Pharmacology|July 1, 1989
Topoisomerase II-mediated DNA cleavage activity induced by ellipticines on the human tumor cell line N417E Multon, J F Riou, D LeFevre, et al.
Anti-Cancer Drug Design|August 14, 1998
Synthesis, DNA binding, topoisomerase II inhibition and cytotoxicity of two guanidine-containing anthracene-9,10-dionesS Routier, J L Bernier, J P Catteau, et al.
Journal of Medicinal Chemistry|May 5, 2000
Multivariate data analysis using D-optimal designs, partial least squares, and response surface modeling: A directional approach for the analysis of farnesyltransferase inhibitorsE Giraud, C Luttmann, F Lavelle, et al.
Development (Cambridge, England)|September 1, 1992
Expression of tenascin mRNA in mesoderm during Xenopus laevis embryogenesis: the potential role of mesoderm patterning in tenascin regionalizationM Umbhauer, J F Riou, J Spring, et al.
Nucleic Acids Research|June 3, 1999
Purification and characterization of human DNA topoisomerase IIIalphaH Goulaouic, T Roulon, O Flamand, et al.
Cancer Research|January 19, 1999
Poisoning of topoisomerase I by an antitumor indolocarbazole drug: stabilization of topoisomerase I-DNA covalent complexes and specific inhibition of the protein kinase activityE Labourier, J F Riou, M Prudhomme, et al.
European Journal of Cancer (Oxford, England : 1990)|February 1, 1997
A carbamate analogue of amsacrine with activity against non-cycling cells stimulates topoisomerase II cleavage at DNA sites distinct from those of amsacrineB C Baguley, F Leteurtre, J F Riou, et al.
Cell and Tissue Research|January 1, 1986
Synthesis and distribution of laminin-related polypeptides in early amphibian embryosT Darribère, J F Riou, D L Shi, et al.
Development (Cambridge, England)|May 1, 1987
Experimental analysis of the extension of the dorsal marginal zone in Pleurodeles waltl gastrulaeD L Shi, M Delarue, T Darribère, et al.
Biochemical Pharmacology|January 26, 1993
Sequential modifications of topoisomerase I activity in a camptothecin-resistant cell line established by progressive adaptationI Madelaine, S Prost, A Naudin, et al.
Pageof 11